Drug & medication recalls Moderate risk

Nystatin Oral Suspension recalled over manufacturing violations

Recall date
January 18, 2017
Source
U.S. Food & Drug Administration (FDA) — enforcement report
Official notice title
VistaPharm, Inc. recalls Nystatin Oral Suspension, USP 100,000 units per mL, a) 2 fl. oz. (60 mL), 24 bottles per case (NDC 66689-008-02), b) 16…
Recall number
D-0457-2017
FDA classification
Class II
Brand / firm
VistaPharm, Inc.
Sold / distributed
Nationwide

Why it was recalled

CGMP Deviations: Purified water used to manufacture the drug products may have been contaminated with Burkholderia cepacia.

Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What was recalled

Nystatin Oral Suspension, USP 100,000 units per mL, a) 2 fl. oz. (60 mL), 24 bottles per case (NDC 66689-008-02), b) 16 fl. oz. (237 mL), 12 bottles per case (NDC 66689-008-16), Rx only, Manufactured by VistaPharm, Largo, FL 33771

Get recall alerts

Free email alert whenever VistaPharm, Inc. has a new recall — straight from official government data. Unsubscribe anytime.

More recalls from: VistaPharm, Inc.